PTSM: Pharmaceutical Technology Sourcing and Management-11-05-2008

Near-stagnant growth for the US pharmaceutical market, the rising influence of emerging markets and specialty products, and increased penetration of generic drugs are major issues for the global pharmaceutical market.

As offshore savings decline, pharmaceutical companies still have a lot of work to do to reduce costs.

Uncertain economic times crimp the financing flow into the US biotechnology industry.